Healthcare
VK2735: Potential Game-Changer in Obesity Treatment and Beyond, Analyst Says
FDA Interaction, Upcoming Data, and Strategic Path Forward Viking Therapeutics (VKTX) continues to make significant strides with its promising candidate...
5 Things You Need To Know Today’s Market Session
Tesla is one step closer to launching full-self driving (FSD) technology in China Tesla (TSLA) is making significant strides towards...
Pfizer’s Lung Cancer Drug Lorbrena Shows Promising Long-Term Results
Potential New Standard Treatment for Advanced ALK-Positive Lung Cancer Pfizer's (PFE) drug Lorbrena has demonstrated promising long-term results in a...
Breakthrough in Feline Health: Vivani’s OKV-119 Implant Shows Promise
New Implant Technology Offers Hope for Managing Obesity and Diabetes in Cats Vivani Medical (VANI) has announced a significant breakthrough...
Eli Lilly Boosts Investment in Indiana Plant to Meet Soaring Drug Demand
$5.3 Billion Expansion to Enhance Supply of Weight Loss and Diabetes Treatments Eli Lilly (LLY) announced a $5.3 billion investment...
Biotech and Tech Stocks Surge Amid Promising Developments
GT Biopharma Shares Soar 148% Amid Positive Q1 Updates and Promising Pipeline Developments GT Biopharma Inc. (GTBP) has experienced a...
Amgen’s Imdelltra Receives FDA Approval as Breakthrough Lung Cancer Treatment
New Therapy Offers Hope for Patients With Advanced Small-Cell Lung Cancer, Extending Survival Rates and Quality of Life The Food...
Oncocyte Announces Bio-Rad Partnership and Raises $15.8M to Accelerate Transplant Diagnostic Launch
Oncocyte's Strategic Collaboration and Financial Discipline Highlight First Quarter Achievements Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, reported key...
Cidara Therapeutics Reacquires Flu Program and Secures $240M in Private Placement
Strategic Shift Allows Cidara Therapeutics to Focus on Cloudbreak Platform for Universal Influenza Protection Cidara Therapeutics, Inc. (Nasdaq: CDTX) reported...
Novavax’s Strategic Leap in Vaccine Development
Novavax's Financial Outlook and Expedites COVID-19 and Influenza Vaccine Initiatives Novavax (NVAX), a leading vaccine developer, has announced a groundbreaking...
